According to animal research, it takes anywhere between 4-7 days until the various potential beneficial effects of BPC-157 occur
Pricing is a transparent flat rate: $299 per month for compounded semaglutide and $499 per month for compounded tirzepatide, regardless of dose
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
The standard answer is 2830 days, refrigerated at 28C
Some researchers report stable results up to 45 or 60 days, but 28 days is the window within which potency is most reliably maintained
Subcutaneous injection represents the most practical administration route for self-administration, offering good bioavailability with minimal technical complexity